Shandong Buchang Pharmaceuticals Co Ltd (603858) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, Shandong Buchang Pharmaceuticals Co Ltd (603858) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-145.26 Million ≈ $-21.26 Million USD) by net assets (CN¥10.07 Billion ≈ $1.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check 603858 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Shandong Buchang Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Shandong Buchang Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 603858 net assets for net asset value and shareholders' equity analysis.

Shandong Buchang Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Buchang Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qingdao Rural Commercial Bank Corp Class A SHE:002958	0.250x
Mister Car Wash, Inc. Common Stock NASDAQ:MCW	0.068x
Bird Construction Inc. TO:BDT	0.440x
Shenzhen Expressway Co Ltd SHG:600548	0.039x
Chengdu Wintrue Holding Co Ltd SHE:002539	-0.031x
Shanghai Luxin Packing Materials Science&Technology Co Ltd SHE:002565	0.007x
Société BIC SA PA:BB	0.173x
Danaos Corporation NYSE:DAC	0.043x

Annual Cash Flow Conversion Efficiency for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shandong Buchang Pharmaceuticals Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥9.81 Billion ≈ $1.44 Billion	CN¥939.95 Million ≈ $137.54 Million	0.096x	+763.71%
2023-12-31	CN¥11.38 Billion ≈ $1.66 Billion	CN¥-164.26 Million ≈ $-24.04 Million	-0.014x	-106.43%
2022-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥2.76 Billion ≈ $403.23 Million	0.224x	+145.65%
2021-12-31	CN¥14.45 Billion ≈ $2.11 Billion	CN¥1.32 Billion ≈ $193.23 Million	0.091x	-35.57%
2020-12-31	CN¥13.81 Billion ≈ $2.02 Billion	CN¥1.96 Billion ≈ $286.63 Million	0.142x	-25.40%
2019-12-31	CN¥13.79 Billion ≈ $2.02 Billion	CN¥2.62 Billion ≈ $383.58 Million	0.190x	+28.47%
2018-12-31	CN¥13.86 Billion ≈ $2.03 Billion	CN¥2.05 Billion ≈ $300.10 Million	0.148x	-0.30%
2017-12-31	CN¥13.22 Billion ≈ $1.93 Billion	CN¥1.96 Billion ≈ $287.10 Million	0.148x	+13.09%
2016-12-31	CN¥12.71 Billion ≈ $1.86 Billion	CN¥1.67 Billion ≈ $244.20 Million	0.131x	-55.07%
2015-12-31	CN¥7.26 Billion ≈ $1.06 Billion	CN¥2.12 Billion ≈ $310.33 Million	0.292x	-27.01%
2014-12-31	CN¥4.45 Billion ≈ $651.08 Million	CN¥1.78 Billion ≈ $260.56 Million	0.400x	+53.90%
2013-12-31	CN¥4.28 Billion ≈ $626.87 Million	CN¥1.11 Billion ≈ $163.01 Million	0.260x	-22.48%
2012-12-31	CN¥4.02 Billion ≈ $588.56 Million	CN¥1.35 Billion ≈ $197.43 Million	0.335x	-39.43%
2011-12-31	CN¥2.80 Billion ≈ $409.96 Million	CN¥1.55 Billion ≈ $227.05 Million	0.554x	--

About Shandong Buchang Pharmaceuticals Co Ltd

SHG:603858 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.32 Billion

CN¥15.88 Billion CNY

Market Cap Rank

#5839 Global

#1207 in China

Share Price

CN¥15.06

Change (1 day)

-1.31%

52-Week Range

CN¥15.06 - CN¥20.02

All Time High

CN¥62.04